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Iron is an essential component of haemoglobin (Hb), required 
for basic cellular function in all human tissues, particularly 
muscle, brain and red blood cells.1  Egg yolk, liver and red 
meat are excellent dietary sources of iron. Vegetarian sources 
include cereals,  pulses and green leafy vegetables, although 
the rate of absorption of iron from these foods is lower.2  Milk 
from any source contains insufficient amounts of iron, making 
babies 3 - 6 months of age vulnerable to iron deficiency.
Worldwide, iron deficiency (usually defined as a ferritin 
level < 12 μg/l) is the most prevalent nutritional deficiency, 
affecting over 2 billion people. Infants, women of childbearing 
age and preschool-aged children are particularly affected since 
iron requirements increase during growth, pregnancy and 
lactation.3  Iron deficiency anaemia (IDA) occurs when iron 
deficiency is sufficiently severe to diminish erythropoiesis, 
leading to a decrease in the number of red cells in the blood 
and resulting in development of anaemia (Hb level < 11 g/
dl).4  It is estimated that of children under 5 years of age, 20% 
in industrialised countries and 39% in non-industrialised 
countries are anaemic.3  
Although conditions such as malaria, nutritional deficiencies 
of folate and vitamin B12, as well as HIV and other chronic 
diseases can play a role in the causal path of anaemia, the 
literature suggests that iron deficiency is responsible for about 
50% of cases of anaemia in young children and pregnant 
women in developing countries.3,4 Schauer and Zlotkin5  
estimated that more than 50% of children under the age of 5 
years in developing countries are anaemic, mainly due to a 
diet that is inadequate in bioavailable iron. The global disease 
burden distribution of IDA is greatly concentrated in sub-
Saharan Africa and Asia.4 
IDA may lower resistance to infections and has been 
shown to delay cognitive and psychomotor development in 
infants, with lasting effects on learning, work productivity, 
health and growth.1,3,6  IDA in early childhood can be fatal, it 
reduces intelligence in mid-childhood, and in the most severe 
form causes mild mental retardation.3,6 In pregnant women it 
increases the risk of a pre-term low-birth-weight delivery, and 
is a risk factor for maternal and perinatal mortality.6
Estimating the burden of disease attributable to iron 
deficiency anaemia in South Africa in 2000
Beatrice Nojilana, Rosana Norman, Muhammad A Dhansay, Demetre Labadarios, Martha E van Stuijvenberg, Debbie Bradshaw 
and the South African Comparative Risk Assessment Collaborating Group
Burden of Disease Research Unit, South African Medical Research Council, 
Tygerberg, Cape Town  
Beatrice Nojilana, Dip Datametrics, Dip Public Health
Rosana Norman, PhD
Debbie Bradshaw, DPhil (Oxon)
Nutritional Intervention Research Unit, South African Medical Research Council, 
Tygerberg, Cape Town 
Muhammad A Dhansay, MB ChB, FCPaed 
Martha E van Stuijvenberg, PhD
Department of Human Nutrition, University of Stellenbosch and Tygerberg 
Academic Hospital, W Cape
Demetre Labadarios, MB ChB, PhD, FACN
Objectives. To estimate the extent of iron deficiency anaemia 
(IDA) among children aged 0 - 4 years and pregnant women 
aged 15 - 49 years, and the burden of disease attributed to IDA 
in South Africa in 2000.
Design. The comparative risk assessment (CRA) methodology 
of the World Health Organization (WHO) was followed using 
local prevalence and burden estimates. IDA prevalence came 
from re-analysis of the South African Vitamin A Consultative 
Group study in the case of the children, and from a pooled 
estimate from several studies in the case of the pregnant 
women (haemoglobin level < 11 g/dl and ferritin level < 12 
μg/l). Monte Carlo simulation-modelling was used for the 
uncertainty analysis.
Setting. South Africa.
Subjects. Children under 5 years and pregnant women 15 - 49 
years.
Outcome measures. Direct sequelae of IDA, maternal and 
perinatal deaths and disability-adjusted life years (DALYs) from 
mild mental disability related to IDA. 
Results. It is estimated that 5.1% of children and 9 - 12% of 
pregnant women had IDA and that about 7.3% of perinatal deaths 
and 4.9% of maternal deaths were attributed to IDA in 2000. 
Overall, about 174 976 (95% uncertainty interval 150 344 - 203 961) 
healthy years of life lost (YLLs), or between 0.9% and 1.3% of all 
DALYs in South Africa in 2000, were attributable to IDA.
Conclusions. This first study in South Africa to quantify the 
burden from IDA suggests that it is a less serious public 
health problem in South Africa than in many other developing 
countries. Nevertheless, this burden is preventable, and the 
study highlights the need to disseminate the food-based dietary 
guidelines formulated by the National Department of Health to 
people who need them and to monitor the impact of the food 
fortification programme. 
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In South Africa nationally representative data on IDA are 
scarce. The South African Vitamin A Consultative Group 
(SAVACG) survey,7 conducted in 1994 - 1995, is the only 
national study that included data on the anaemia and iron 
status of children aged 6 - 71 months. The prevalence of 
anaemia was 21%. The prevalence of IDA in children was 5% 
using the bivariate criteria (Hb < 11 g/dl and ferritin < 12 μg/l) 
and 3% using the trivariate criteria analysis (also including 
low mean corpuscular volume). Other smaller-scale studies8-10 
done before the SAVACG study showed a higher prevalence 
of IDA of 10 - 50% in infants and young children. In addition, 
Oelofse et al.11 found the prevalence of iron deficiency among 
preschoolers in rural KwaZulu-Natal to be 19.8%, and 18.9% 
of mothers were iron deficient but not necessarily anaemic. 
Mayet et al.12 found that 42% of males and 53% of females aged 
6 - 74 years in a rural setting in KwaZulu-Natal were anaemic, 
largely as a result of low iron intake.11,12 While these studies 
may have been conducted among vulnerable communities, 
provincial variations in the prevalence of anaemia range from 
10% in KwaZulu-Natal to 34% in Limpopo, suggesting that 
there are considerable variations in the prevalence of anaemia 
and IDA.11-13  
In the case of pregnant women there are no national data 
on the extent of IDA. Studies have reported the prevalence of 
anaemia in pregnancy to be between 22% and 35% in Durban, 
27% and 37% in Johannesburg, and 33% in Gazankulu.13 A 
study by Kruger et al.14  observed anaemia in 25% of pregnant 
and 10% of non-pregnant women in a so-called ‘coloured’ 
suburb in the Cape Peninsula. Iron deficiency was observed 
in 21% of the pregnant and 13% of the non-pregnant women, 
while the prevalence of IDA (Hb < 11 g/dl and serum ferritin 
<12 μg/l) was 9% and 7% respectively.14 A study of women 
attending antenatal clinics in Durban15 found that iron 
deficiency was common among pregnant women, especially 
women of Indian origin. The prevalence of anaemia in the third 
trimester of pregnancy was reported at 47% of Indian and 29% 
of black African women.15  The prevalence of iron deficiency 
(serum ferritin < 12 μg/l) in the third trimester of pregnancy 
was 86% in Indian women and 40% in black African women. 
However, the prevalence of IDA was not reported. Dannhauser 
et al.16 reported a 26.2% prevalence of anaemia among pregnant 
women living in Bloemfontein, and a 20% prevalence of IDA.
As part of a comparative risk assessment (CRA), the aim of 
this study was to estimate the extent of IDA among children 
aged 0 - 4 years and pregnant women using the available data, 
and to quantify the burden of disease from other causes that 
can be attributed to this form of micronutrient malnutrition in 
South Africa in 2000. 
Methods  
It is assumed that iron deficiency contributes to death and 
disability through direct sequelae as in the Global Burden of 
Disease Study,17,18  or as a risk factor for death and disability 
from other causes. We followed the framework developed by 
Stoltzfus et al.,3 in which IDA among pregnant women was 
considered a risk factor for perinatal mortality and maternal 
mortality (not morbidity). According to the framework, 
women die of heart failure due to blood loss which is made 
more precipitous by IDA.3 Similarly, a baby would die in the 
perinatal period from causes related to pre-term birth, for 
which maternal iron deficiency is a risk factor. Decreased 
work productivity and delayed child development (reduction 
in intelligence) are considered to be direct sequelae of iron 
deficiency, the assumption being that iron deficiency directly 
causes decreased oxygen delivery to muscles and the brain. 
The Hb cut-offs used to define anaemia are from Stoltzfus 
and Dreyfuss19 and have not changed since the 1990 WHO 
anaemia database was created. For both children 0 - 4 years 
and pregnant women an Hb cut-off of 11 g/dl is used to define 
anaemia in populations living at sea level. Either bivariate (Hb 
< 11 g/dl + serum ferritin < 12 μg/l) or trivariate (Hb < 11 g/dl 
+ ferritin < 12 μg/l + mean corpuscular volume) criteria can 
be used to define IDA. For this analysis we used the definition 
based on bivariate criteria.
The standardised CRA method for estimating population-
attributable fractions (PAFs) and attributable burden was 
used in this study. As has been fully described elsewhere,1,3,20 
attributable burdens were calculated using potential impact 
fractions, which are multi-level extensions of attributable 
fractions. As in the global study,3 the theoretical minimum 
distribution represents the Hb distribution in the population if 
iron deficiency was eliminated. 
The shift in the mean Hb concentration for children aged  
0 - 4 years if iron deficiency was eliminated was estimated by 
assuming that for a prevalence of anaemia of between 15% 
and 30%, the Hb is normally distributed,21 with a standard 
deviation (SD) of 1.2 g/dl.3 The shift in mean Hb level is then 
converted to the shift in the distribution of IQ points using 
the method described by Stoltzfus and colleagues,3 so as to 
estimate the proportion of children with IQ points just above 
the threshold who would enter the mild mental disability 
(MMD) range due to IDA. By convention, MMD occurs when 
the IQ is below 70 points but above 50 points. Intelligence in 
human populations approximates to a normal distribution with 
a mean of 100 (95% confidence interval (CI): 98 - 102) and a 
standard deviation of 15 IQ points.22,23   
The increase in risk of MMD is estimated from the 
expected mean change in IQ, by assuming that the mean 
change represents a shift in the entire distribution of values 
with no change in the variance of the distribution.3 For low 
concentrations of Hb the estimated increase in IQ points 
associated with a 1 g/dl increase in Hb concentration is 
1.73 (95% CI: 1.04 - 2.41).3 The rate of MMD due to IDA is 
the difference between the predicted rate of MMD in our 
population with the Hb distribution shifted downward due to 
iron deficiency, and the expected rate in the healthy population 
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(2.28%). The disease modelling tool DisMod II24 was then used 
to back-calculate the incidence of MMD from the observed 
prevalence rate, using a relative risk (RR) of total mortality for 
mental disability of 2 (double that for the total population) and 
a remission rate of 0. For estimating the disability-adjusted life 
years (DALYs) due to MMD, this calculated incidence of MMD 
was introduced into the DALY template MS Excel spreadsheets 
with duration and age at onset also derived from DisMod II 
and using the Dutch disability weight for MMD of 0.290.25 
In the case of pregnant women we similarly used the 
prevalences of IDA to derive the theoretical minimum 
prevalence of anaemia, and converted this to a mean Hb 
level assuming an SD of 1.2 g/dl to estimate the theoretical 
minimum risk distribution representing the Hb distribution, 
if iron deficiency were eliminated. The RR estimates for IDA 
used in these analyses were those published by Stoltzfus 
et al.3 The odds ratios associated with a l g/dl increase in 
population mean Hb level were 0.80 (95% CI: 0.70 - 0.91) for 
maternal mortality and 0.72 (95% CI: 0.65 - 0.80) for perinatal 
mortality (Africa region), and have been adjusted by 20% for 
confounding factors.3
PAFs by cause were calculated in MS Excel using the discrete 
version of the general potential impact fraction taking into 
account continuous risk factor disease exposures compared 
with a theoretical minimum distribution (conferring the lowest 
possible risk) on a categorical scale: 
where n = the number of exposure categories; Pi = the 
proportion of population in exposure category i; RRi = the 
relative risk for exposure category i; and P’i = the proportion 
of population in exposure category i in the counterfactual 
distribution. 
The PAFs were then applied to revised burden of disease 
estimates for South Africa, 2000, for the maternal and perinatal 
disease categories.26  DALYs attributed directly to IDA were 
also included as these estimates include the direct effects of 
IDA on work productivity, child development and cognition. 
DALY estimates of IDA in the 0 - 4-year age group were 
excluded to avoid double counting from the inclusion of the 
MMD DALYs estimated in this analysis.
Monte Carlo simulation-modelling techniques were used to 
present uncertainty ranges around point estimates that reflect 
the main sources of uncertainty in the calculations.   
@RISK software version 4.5 for Excel27 was used, which 
allows multiple recalculations of a spreadsheet, each time 
choosing a value from distributions defined for input variables. 
Normal distributions were specified for the prevalence input 
variables, based on standard errors of the mean Hb values in 
pregnant women. In order to derive the theoretical minimum 
distribution for pregnant women, a uniform probability 
distribution was specified between the upper and lower 
Hb values corresponding to the minimum and maximum 
prevalence of anaemia, after subtracting the respective 
maximum and minimum prevalence of IDA from published 
studies. 
Similarly, to derive uncertainty ranges around the Hb shift 
in children 0 - 4 years of age (or the difference between the 
current observed Hb level and the theoretical minimum level 
if IDA is eliminated), first a uniform probability distribution 
was specified between the upper and lower Hb values, 
corresponding to the upper and lower confidence limits of the 
observed anaemia prevalence. Secondly, a uniform probability 
distribution was specified between the upper and lower 
Hb values, corresponding to the minimum and maximum 
prevalence of anaemia after subtracting the respective 
maximum and minimum prevalence of IDA from published 
studies. 
For the RR input variables we specified a normal distribution 
around the logged point estimate and its standard error 
derived from the published values and their 95% confidence 
intervals.3 A uniform probability distribution with a minimum 
of 98 and a maximum value of 102 was specified for the mean 
IQ in human populations. A uniform probability distribution 
was also specified around the estimated increase in IQ points 
associated with a 1 g/dl increase in Hb, concentration based 
on the lower and upper limits of the published 95% CI. For 
each of the output variables (namely attributable burden 
as a percentage of total burden in South Africa 2000), 95% 
uncertainty intervals were calculated bounded by the 2.5th and 
97.5th percentiles of the 2000 iteration values generated. 
Results 
Re-analysis of SAVACG data7 for children 0 - 4 years of 
age yielded a prevalence of anaemia of 22.6% (95% CI 21.1 
- 24.2%) and a prevalence of IDA of 5.1% (95% CI 4.3 - 5.9%). 
It can therefore be estimated that more than 0.2 million 
children were affected by this form of iron deficiency in our 
country in 2000, and that about a quarter of the anaemia 
in South African children is IDA. This is in contrast to the 
global study,3 which estimated that 50% of anaemia is IDA. 
The theoretical minimum prevalence of anaemia, if iron 
deficiency were eliminated, would be between 17% and 18%. 
Assuming a normal distribution with an SD of 1.2 g/dl, the 
shift in population mean Hb concentration representing the 
elimination of IDA was 0.22 g/dl (95% uncertainty interval 0.14 
- 0.30 g/dl) for children of 0 - 4 years of age. 
The estimated decrease in IQ points associated with this 
downward shift in population mean Hb concentration of 0.22 
g/dl was estimated at 0.38 (95% CI: 0.19 - 0.64). Based on this 
shift, the rate of MMD due to IDA was estimated at 0.14% (95% 
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uncertainty interval: 0.07 - 0.26%), and represents an incidence 
of MMD of 0.7 per 1 000 in the 0 - 4-year age group. Using 
this incidence, an estimated 29 673 DALYs due to MMD were 
causally attributed to IDA. 
Local studies conducted in pregnant women reported a 
prevalence range of 9 - 12% for IDA,14-16,28-30 affecting more than 
100 000 births in 2000. The prevalence in pregnant women was 
about double that observed in children. The weighted mean 
Hb concentration in the community studies was 11.6 g/dl 
for pregnant women. Assuming a normal distribution with 
an SD of 1.2 g/dl, this pooled mean indicates a prevalence of 
anaemia of 30.4%. The predicted Hb shift for pregnant women 
representing the elimination of iron deficiency was also higher 
than in children, and was estimated to be around 0.47 g/dl 
(95% uncertainty interval 0.37 - 0.57 g/dl). Based on this, about 
7.3% of perinatal deaths and 4.9% of maternal deaths could 
be attributed to IDA in pregnant women, amounting to 1 938 
perinatal and 100 maternal deaths.
Overall, an estimated 2 038 deaths (95% uncertainty interval 
1 292 - 2 914) or 0.4% of all deaths in South Africa in 2000 could 
be attributed to IDA (Table I).  Attributable DALYs were higher, 
with 174 976 (95% uncertainty interval 150 344 - 203 961) healthy 
years of life lost (YLLs), or between 0.9% and 1.3% of all DALYs 
in South Africa in 2000 attributable to IDA. The perinatal burden 
accounted for 36.7% of all DALYs attributable to IDA, while 
maternal mortality (1.7%) and MMD (17.0%) accounted for much 
smaller proportions of the total attributable burden (Fig. 1).   
Discussion
The global study3 found that in total, 0.8 million deaths 
worldwide (1.5%) are attributable to IDA. Using a comparable 
method with South African data, the present study indicates 
that some 2000 deaths (95% uncertainty interval 1 300 - 2 
900) could be attributed to IDA, accounting for 0.2 - 0.4% 
of total deaths in South Africa in the year 2000. The present 
study estimated that about 7% of perinatal deaths and 5% of 
maternal deaths were attributed to IDA, while the global study 
estimated that about 20% of perinatal mortality and 10% of 
maternal mortality in developing countries is attributable to 
iron deficiency.1,3 
There are two possible reasons for the lower proportion of 
attributable deaths in South Africa. Firstly, the observed IDA 
prevalence of 9 - 12% in pregnant women, although higher 
than the 4% estimated for industrialised countries, is much 
lower than the 20 - 25% estimated for sub-Saharan Africa, 
South-East Asia and the Western Pacific Regions.1 The second 
reason is the high HIV/AIDS burden in South Africa, which 
has the effect of reducing the relative contribution of other 
conditions. 
The global study8 estimated that 2.4% of DALYs are 
attributable to IDA, higher than the proportion of attributable 
deaths. For South Africa, 174 976 (95% uncertainty interval  
150 344 - 203 961) healthy YLLs, or between 0.9% and 1.3% of 
all DALYs, were attributable to IDA. IDA is ranked 13th overall 
in terms of DALYs compared with 17 risk factors assessed in 
South Africa, ranking lower than ‘underweight’ but higher 
than other forms of micronutrient deficiencies such as vitamin 
A deficiency. While IDA appears to be of less serious public 
health importance in South Africa than the rest of sub-Saharan 
Africa, it is important to acknowledge the geographical 
Table I. Disease burden attributable to IDA, South Africa, 2000
Related outcomes    Attributable mortality     Attributable DALYs
Perinatal mortality                                1 938           64 254
Maternal mortality                                   100             3 048
MMD                                       0           29 673
IDA*                                       0           78 002
Total attributable burden                               2 038         174 976
         95% uncertainty interval                   1 292 - 2 914          150 344 - 203 961
 % of total burden                                 0.4%             1.1%
        95% uncertainty interval                        0.2 - 0.6%                     0.9 - 1.3%
*Direct sequelae attributed directly to iron deficiency in persons 5 years and older (there were no deaths due to IDA).26
DALYs = disability-adjusted life years; MMD = mild mental disability; IDA = iron-deficiency anaemia.
Fig. 1. Disease burden attributable to IDA, South Africa, 2000.
Attributable DALYs = 174 976
Persons
r
Iron deficiency anaemia
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differences across the country. In addition, IDA is an important 
risk factor in children, ranking 4th overall and accounting for 
2.3% (1.7 - 3.0%) of all healthy years lost in children aged  
0 - 4 years. Since this burden is preventable and amenable to 
interventions, it is important to identify ways in which this can 
be reduced. 
It should be noted that there is a degree of uncertainty in the 
results that could not be quantified. One of the limitations of 
using bivariate analysis is that serum ferritin concentrations 
could have been increased due to infection, obscuring the 
presence of iron deficiency.31  However, this masking is not 
likely to be substantial in this study since the SAVACG study7 
specifically excluded children with fever. Furthermore, the 
small community studies8-10 show higher prevalences in 
children than reflected in the SAVACG study. It is not clear 
whether the studies were conducted in atypical settings, or 
whether the national survey underestimated the extent of 
the problem. A second contribution to the uncertainty of this 
estimate is that the data used to determine the prevalence of 
IDA are dated. The study results are also compromised by the 
lack of national prevalence data for pregnant women. 
Measurement of IDA in population studies remains a 
challenge. In the community studies in pregnant women 
only bivariate criteria were used to diagnose IDA, whereas 
in SAVACG both trivariate and bivariate criteria were used 
to define IDA in children. Applying the more conservative 
trivariate criteria to define IDA in the SAVACG data yielded 
a similar prevalence that falls within the uncertainty range 
used in this analysis. It is therefore believed that the use of 
bivariate criteria would not have led to an overestimate of 
the attributable burden in children in this analysis. However, 
it would be ideal to be able to use serum transferrin receptor 
levels as an indicator of iron deficiency.32  
Stoltzfus et al.3 point out the need for more research in 
the context of high anaemia prevalence worldwide. They 
stress that the estimates of decreased IQ and MMD related to 
IDA presented for children under 5 years of age should also 
be interpreted with caution.4 Evidence for the relationship 
between IDA and maternal and perinatal mortality needs to be 
researched further, and there is also an urgent need for more 
consistent data on the association between IDA and mortality 
as well as mental disability in young children.  
Conclusion and recommendations
IDA appears to be of less serious public health importance in 
South Africa than in the rest of sub-Saharan Africa and some 
of the other regions in the world. In spite of the need for more 
recent evidence on the prevalence of IDA, this study suggests 
that there is a preventable burden resulting from IDA in South 
Africa. Food-based approaches are needed to direct efforts 
towards promoting the availability of and access to iron-rich 
foods. In addition, focus should be placed on the consumption 
of foods that enhance the absorption or utilisation of iron, such 
as fruit and vegetables. The challenge remains to ensure that 
the food-based dietary guidelines developed by the National 
Department of Health33 reach the people who need them.  
Food fortification is an effective long-term approach to 
improve the iron status of the population. Following the 
National Food Consumption Survey of 1999,34 in which it was 
found that at least one-third of children have an intake of less 
than half the recommended levels of important nutrients, 
legislation has been introduced to enforce the fortification 
of wheat flour and maize meal. Iron is one of the minerals 
included in the fortification, and careful assessment of the 
efficiency and effectiveness of these interventions, as well as of 
the impact on vulnerable subgroups, is needed. 
It is not clear whether iron supplementation for target 
groups is needed. Further research is recommended to update 
information on the prevalence of iron deficiency and IDA by 
age and gender and to identify vulnerable groups. Measures 
to improve nutrition knowledge and awareness of mothers 
and health workers may be implemented. Finally, nutrition 
education and intervention programmes should address iron 
deficiency with the focus on both dietary quantity and quality 
of the micronutrient composition. All of these interventions 
must be monitored for effectiveness. 
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